Thomas Benfield, MD DTMH DMSc;

Department of Infectious Diseases / CREDID

Copenhagen University Hospital – Amager and Hvidovre

Kettegaard Alle 30, 2650 Hvidovre, Denmark

ORCID ID: https://orcid.org/0000-0003-0698-9385

Autorisation ID: 00NSC (Board of Health, Denmark)

Medical degree (MD) from the University of Copenhagen in January 1992

Doctoral degree (DMSc) from the University of Copenhagen in January 2003

Current position(s): Professor - University of Copenhagen (August 2014-); Consultant – Department of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre (October 2007-); Director of Clinical Research, Dept. of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre (October 2007-); Editor-in-chief, Danish Medical Journal (2021-) and Director, Center of Clinical Research & Disruption of Infectious Diseases (CREDID) (2020-). Deputy Head, Department of Clinical Medicine, University of Copenhagen (2024-). All Denmark.

Professional career:

Trained in internal medicine and infectious diseases:

Department of Reumatology, Hvidovre Hospital, Denmark (internship 1992)

Department of Infectious Diseases, Hvidovre Hospital, Denmark (internship 1992-93, 1997)

Fellowship at Critical Care Medicine Dept., National Institute of Health, USA (1994-95)

Department of Infectious Diseases, Hvidovre Hospital, Denmark (research assistent 1995-97)

Department of Internal Medicine, Roskilde Hospital, Denmark (residenceship 1997-98)

Department of Pulmonary Medicine, Hvidovre Hoopital, Denmark (fellow 1998-99)

Department of Nephrology, Rigshospitalet, Denmark (fellow 1999-2000)

Department of Oncology, Rigshospitalet, Denmark (fellow 2000)

Department of Infectious Diseases, Rigshospitalet, Denmark (fellow 2000-2005)

Copenhagen HIV Programme, Hvidovre Hospital, Denmark (deputy director 2005-06)

Department of Infectious Diseases, Hvidovre Hospital, Denmark (senior fellow 2006-07)

Lifelong clinician scientist career with a focus on basic and clinical research within HIV / AIDS, hepatitis C, sepsis and pneumonia. Clinical trial focus on sepsis, pneumonia, HIV and viral respiratory infections (COVID-19, influenza and RSV). Investigator and subinvestigator of clinical phase I-III trials of antiretrovirals, antivirals and vaccines. Clinical management of patients infected with sepsis, pneumonia, meningitis, tuberculosis, HIV, hepatitis B and C. Chaired phase I, II and III Data Safety Monitoring Boards.

Good Clinical Practice training: GCP Unit (http://www.gcp-enhed.dk/en/forside/) on March 1, 2023

Clinical Trial Experience:  Sponsor (5), or primary investigator (5) of 10 on-going investigator- or industry-initiated trials within infectious diseases. Participation in > 30 prior randomized clinical trials.

Steering committee member of Trial Nation Infectious Disease and Immune Therapy (http://trialnation.dk).

Research group/leadership: PhD students: 5. Post docs: 1. Pregraduate research students: 2. Technician: 1. Statistician: 1. Study nurses: 2. Past PhD students: 12 (main supervisor) and 10 (co-supervisor). Past bachelor and graduate students: 43.

Honors: Hartmann Prize (2021), Danish Medical Association Honour Prize (2021), William Nielsen Award (2022)

Research grants: > € 3.000.000 in past five years including Novo Nordisk Foundation Investigator-initiated Clinical Research Grant 2018 (DKK 7.605.137, NNF18OC0034666), Lundbeck Foundation (DKK 5.000.000), Independent Research Fund Denmark (co-applicant DKK 2.200.000).

Dr. Benfield reports grants from Novo Nordisk Foundation, Lundbeck Foundation, Simonsen Foundation, GSK, and Pfizer; personal fees from GSK, Pfizer, Bavarian Nordic, Gilead, MSD, Janssen, Moderna and Astra Zeneca; outside the submitted work.